Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mankind Pharma Reports 38% Profit Growth as Exports Lead Segment Gains
India-based Mankind Pharma's consolidated profit after tax rose 37.7% in the quarter ended Sept. 30, as exports led its business segments and consumer healthcare revenue barely moved. After-tax earnings on a consolidated basis totaled…
Hengrui Pharma reports 88.9% rise in 2026 third-quarter profit on licensing deals
BEIJING, Oct 27 (Reuters) – Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, reported on Tuesday a rise of 88.9% in profit for the third quarter of 2026, driven by income from out-licensing deals. •…
Is govt allowing pharma companies to overprice medicines? SC flags massive gap in MRP and retailer cost
The Supreme Court on Tuesday slammed the Centre over the massive difference between the MRP of medicines and their purchase price for retailers, questioning who is monitoring drug prices in the country. A bench of Justices Vikram Nath and Sandeep…
Nuvectis Pharma (NVCT) Projected to Release Quarterly Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to post earnings of ($0.22) per share for the quarter. Individuals can find…
OKYO Pharma (NASDAQ:OKYO) Stock Price Up 2.9% - Here's Why
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report)'s stock price rose 2.9% during trading on Monday. The company traded as high as $1.44 and last traded at $1.44. Approximately 16,654 shares traded hands during trading, a decline of…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Moved Up to 'Hold' by Canaccord Genuity Group
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by investment analysts at Canaccord Genuity Group to a 'hold' rating in a research report issued to clients and investors on Monday, Zacks reports. Can BioMarin Stock Live Up to Wall…
Ascendis Pharma A/S $ASND Stock: Nisa Investment Advisors LLC Increases Position
Nisa Investment Advisors LLC increased its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 28,468.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor…
Sterling Capital Management LLC Sells 39,687 Shares of Royalty Pharma PLC $RPRX
Sterling Capital Management LLC cut its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 60.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Should You Sell?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s stock price gapped down before the market opened on Tuesday. The stock had previously closed at $15.45, but opened at $14.69. Ascentage Pharma Group…
Indian Stock Markets Unchanged: Crude Oil Prices, Bank Stocks, US Fed Policy Impact
Indian stock markets, including the Sensex and Nifty, concluded a volatile trading day largely unchanged, grappling with persistently high crude oil prices, significant selling in key bank stocks, and a cautious outlook ahead of the crucial US…
AbbVie: Analyzing Performance, Pipeline, And Pricing Ahead Of Q3 (Strong Buy) (NYSE:ABBV)
AbbVie Inc. is trading at all-time highs, with robust 2026 guidance and a market cap exceeding $500bn. I expect ABBV Q3 earnings to outperform, driven by immunology assets Skyrizi and Rinvoq, which together will generate over $30bn in 2026. Despite…
IQVIA (IQV) Q3 2026 Earnings Call Transcript
Senior Vice President, Investor Relations - Kerri Joseph Chairman and Chief Executive Officer - Ari Bousbib Executive Vice President and Chief Financial Officer - Michael J. Fedock Executive Vice President and General Counsel - Eric Sherbet Senior…
Nifty Prediction Today - October 27, 2026: Nifty futures: Breakout expected
Nifty 50 opened today's session lower at 22,709 versus Monday's close of 22,753. It is now trading at 22,730, down by a marginal 0.1 per cent. The advance/decline ratio of Nifty 50 now stands at 26/24. Tata Consumer Products (up 5.7 per cent) and…
'Why do we value a Mars bar more than life-saving medicine?' Sandoz CEO calls for level playing field with cheap Chinese antibiotics
Prior to Alexander Fleming's accidental discovery of penicillin 100 years ago, almost half of all deaths were caused by infections. Fleming's petri-dish experiments and the resulting development of modern antibiotics have added an average of 23…
Stock markets end largely unchanged amid elevated crude oil prices, selling in bank stocks
Market benchmark indices Sensex and Nifty ended largely unchanged in a highly volatile trade on Tuesday (October 27, 2026) amid persistently elevated crude oil prices, selling in blue-chip bank stocks and caution ahead of the U.S. Federal Reserve's…
Receive a Daily briefing on Pharma Industry News
Get Started